HLA
IMI

Hamilton Lane Advisors’s Intermolecular, Inc. IMI Stock Holding History

Hamilton Lane Advisors’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-25,500
Closed -$71K – 73
2014
Q1 		$71K Buy
+25,500
New +$92.8K 0.03% 65

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Hamilton Lane Advisors's IMI Position: Q2 2014 in Review

Hamilton Lane Advisors sold out of Intermolecular, Inc. (IMI) in Q2 2014, closing a stake of 25,500 shares — an estimated $71K sold.

Hamilton Lane Advisors first reported a position in IMI in Q1 2014 and held it in 1 quarter. The position peaked at $71K in Q1 2014. 43 funds tracked by Wall St. Rank hold IMI as of Q2 2014.

  • Hamilton Lane Advisors reported no remaining Intermolecular, Inc. position as of Q2 2014 after selling out during the quarter.
  • Hamilton Lane Advisors sold 25,500 Intermolecular, Inc. shares in Q2 2014, an estimated $71K.
  • Hamilton Lane Advisors first reported a position in Intermolecular, Inc. in Q1 2014 and held it in 1 quarter.
  • Hamilton Lane Advisors's Intermolecular, Inc. position peaked at $71K in Q1 2014.
  • 43 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2014.

Based on Hamilton Lane Advisors's 13F filing for Q2 2014, filed 2 Jul 2014.